138 related articles for article (PubMed ID: 11589268)
1. Pharmacoeconomics under defined contributions and tiered formularies.
Lyles A
Clin Ther; 2001 Sep; 23(9):1568-9. PubMed ID: 11589268
[No Abstract] [Full Text] [Related]
2. Companies leaning on workers in battle against pharmacy costs.
Diamond F
Manag Care; 2002 Nov; 11(11):44-5. PubMed ID: 12491858
[No Abstract] [Full Text] [Related]
3. Firms help companies carve savings from drug spending.
Kenkel PJ
Mod Healthc; 1992 May; 22(21):34. PubMed ID: 10118148
[No Abstract] [Full Text] [Related]
4. [Economic drug prescription].
Engelbrecht N; Gramkow M
Ugeskr Laeger; 2003 Dec; 165(50):4871-2. PubMed ID: 14716910
[No Abstract] [Full Text] [Related]
5. Keeping prescription drugs affordable.
Arp D
Healthplan; 2002; 43(6):12-5. PubMed ID: 12506430
[No Abstract] [Full Text] [Related]
6. Rising drug prices drive US manufacturers' revenues, analysis finds.
McCarthy M
BMJ; 2015 Oct; 351():h5376. PubMed ID: 26446098
[No Abstract] [Full Text] [Related]
7. Managing prescription drug costs.
Sica JM
Empl Benefits J; 2001 Mar; 26(1):35-40. PubMed ID: 11272515
[TBL] [Abstract][Full Text] [Related]
8. Pharmacoeconomics: basic concepts and terminology.
Walley T; Haycox A
Br J Clin Pharmacol; 1997 Apr; 43(4):343-8. PubMed ID: 9146844
[No Abstract] [Full Text] [Related]
9. Prescription costs and controls.
Bus Health; 2001 Dec; 19(12 Suppl A):8-11. PubMed ID: 11799642
[No Abstract] [Full Text] [Related]
10. Pharmacoeconomics: the new dismal science.
Luchins DJ
Adm Policy Ment Health; 2004 May; 31(5):425-7. PubMed ID: 15379388
[No Abstract] [Full Text] [Related]
11. Control of prescription costs--is it possible?
Renaud PN
Empl Benefits J; 2002 Mar; 27(1):11-4. PubMed ID: 11859536
[TBL] [Abstract][Full Text] [Related]
12. Benefit trends work against providers managing drug risk.
Capitation Rates Data; 2000 Mar; 5(3):34-6. PubMed ID: 11010134
[No Abstract] [Full Text] [Related]
13. Projecting future drug expenditures--1999.
Mehl B; Santell JP
Am J Health Syst Pharm; 1999 Jan; 56(1):31-9. PubMed ID: 10048877
[TBL] [Abstract][Full Text] [Related]
14. The American health care system--expenditures.
Iglehart JK
N Engl J Med; 1999 Jan; 340(1):70-6. PubMed ID: 9878649
[No Abstract] [Full Text] [Related]
15. Employers push to manage prescription drug costs.
Frieden J
Bus Health; 1992 May; 10(6):43-6, 48, 50. PubMed ID: 10119119
[No Abstract] [Full Text] [Related]
16. Pharmacy discount card programs: catching up with the health markets.
Edwards D
Empl Benefits J; 2002 Sep; 27(3):42-3. PubMed ID: 12219563
[TBL] [Abstract][Full Text] [Related]
17. Prescription drugs: recent trends in utilization, expenditures, and coverage.
Sethi RC
EBRI Issue Brief; 2004 Jan; (265):1-35. PubMed ID: 14969223
[No Abstract] [Full Text] [Related]
18. Prescription drug copayments--fiduciary duty--plan discounts--disclosure. Alves v. Harvard Pilgrim Health Care, Inc.
Benefits Q; 2005; 21(2):61-3. PubMed ID: 15977753
[No Abstract] [Full Text] [Related]
19. Precipitating factors for pharmaceutical firms.
McCarthy R
State Health Care Am; 1997; ():39-43. PubMed ID: 10168083
[No Abstract] [Full Text] [Related]
20. Health economics in primary care in the UK: containment of drug costs.
Walley T; Edwards RT
Pharmacoeconomics; 1993 Feb; 3(2):100-6. PubMed ID: 10146959
[No Abstract] [Full Text] [Related]
[Next] [New Search]
